• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[A case of leiomyosarcoma of prostate: multimodality therapy suppressed disease progression for long term].

作者信息

Hayashi Takuji, Nakai Yasutomo, Kakuta Youichi, Takayama Hitoshi, Nakayama Masashi, Nonomura Norio, Okumi Masayoshi, Nakao Atsushi

机构信息

The Department of Urology, Osaka University.

出版信息

Hinyokika Kiyo. 2010 Sep;56(9):527-30.

PMID:20940530
Abstract

A 67-year-old man presented with macroscopic hematuria. Transrectal prostatic needle biopsy was performed because of elevated prostate specific antigen (PSA) (3.85 ng/ml) and palpation of hard nodules at the prostate. Pathological diagnosis was leiomysarcoma. Computed tomography revealed several pulmonary metastases. Radical cysto-prostatectomy and construction of ileal conduct were performed. Adjuvant radiotherapy (50 Gy) was also performed. During follow-up, the size of the pulmonary metastases increased, and we decided to start systemic chemotherapy 7 months after surgery. The chemotherapy consisted of gemcitabine (900 mg/m2 on day 1 and day 8), and docetaxel (100 mg/m2 on day 8). After eight courses, there was 20% reduction in the size of some pulmonary metastases. He remained alive 21 months after diagnosis.

摘要

相似文献

1
[A case of leiomyosarcoma of prostate: multimodality therapy suppressed disease progression for long term].
Hinyokika Kiyo. 2010 Sep;56(9):527-30.
2
[Long-term survival with gemcitabine and docetaxel for renal leiomyosarcoma : a case report].
Hinyokika Kiyo. 2013 Aug;59(8):497-501.
3
Primary leiomyosarcoma of the seminal vesicle: case report and review of the literature.精囊原发性平滑肌肉瘤:病例报告及文献复习。
BMC Cancer. 2011 Jul 29;11:323. doi: 10.1186/1471-2407-11-323.
4
Chemotherapy with Gemcitabine and Cisplatin for Advanced Ductal Adenocarcinoma of the Prostate: Clinical Courses of Two Patients.吉西他滨和顺铂联合化疗用于晚期前列腺导管腺癌:两名患者的临床病程
Tohoku J Exp Med. 2015 Dec;237(4):317-21. doi: 10.1620/tjem.237.317.
5
Gemcitabine and Docetaxel Compared With Observation, Radiation, or Other Chemotherapy Regimens as Adjuvant Treatment for Stage I-to-IV Uterine Leiomyosarcoma.吉西他滨与多西他赛对比观察、放疗或其他化疗方案作为Ⅰ至Ⅳ期子宫平滑肌肉瘤辅助治疗的疗效
Int J Gynecol Cancer. 2016 Mar;26(3):505-11. doi: 10.1097/IGC.0000000000000634.
6
[Marked efficacy of multimodality therapy for ureteral cancer producing granulocyte colony-stmimulating factor].[多模态疗法对产生粒细胞集落刺激因子的输尿管癌具有显著疗效]
Nihon Hinyokika Gakkai Zasshi. 2014 Apr;105(2):43-6. doi: 10.5980/jpnjurol.105.43.
7
Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.吉西他滨与长春瑞滨序贯每周多西他赛用于晚期非小细胞肺癌患者:一项序贯化疗的II期试验
Clin Transl Oncol. 2006 Oct;8(10):742-9. doi: 10.1007/s12094-006-0121-x.
8
Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: Results of a prospective study.吉西他滨联合多西他赛辅助治疗完全切除的Ⅰ-Ⅳ期高级别子宫平滑肌肉瘤:一项前瞻性研究的结果
Gynecol Oncol. 2009 Mar;112(3):563-7. doi: 10.1016/j.ygyno.2008.11.027. Epub 2009 Jan 9.
9
Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer.多西他赛、吉西他滨和泼尼松在去势抵抗性转移性前列腺癌中的 I/II 期研究。
Cancer Chemother Pharmacol. 2010 Jul;66(2):295-301. doi: 10.1007/s00280-009-1163-x. Epub 2009 Oct 31.
10
[Leiomyosarcoma of the prostate treated with neoadjuvant intra-arterial chemotherapy and pelvic excenteration ; a case report].[新辅助动脉内化疗及盆腔脏器清除术治疗前列腺平滑肌肉瘤;病例报告]
Hinyokika Kiyo. 2014 Nov;60(11):579-82.

引用本文的文献

1
Long term follow-up of surgery management of prostate leiomyosarcoma metastasized to the rib: A case report and literature review.前列腺平滑肌肉瘤转移至肋骨手术治疗的长期随访:1例报告及文献复习
Mol Clin Oncol. 2016 Jul;5(1):132-134. doi: 10.3892/mco.2016.898. Epub 2016 May 11.